Cara Therapeutics Inc. (CARA)
5.00
-0.15 (-2.91%)
At close: Mar 31, 2025, 12:14 PM
Cara Therapeutics Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Revenue | 7.14M | 20.97M | 41.87M | 23.03M | 135.08M | 19.89M | 13.47M | 911K | 86K | 3.8M | 3.18M | 11.96M | 1.19M | n/a |
| Cost of Revenue | n/a | 6.17M | 7.27M | 1.55M | 107.07M | 113.16M | 75.53M | 48.52M | 49.25M | 21.22M | 15.07M | 8.69M | 1.92M | n/a |
| Gross Profit | 7.14M | 14.79M | 34.6M | 21.47M | 28.01M | -93.28M | -62.06M | -47.61M | -49.17M | -17.42M | -11.89M | 3.28M | -731K | n/a |
| Operating Income | -58.38M | -121.5M | -87.53M | -89.08M | 5.38M | -111.68M | -77.38M | -59.48M | -58.4M | -25.19M | -18.07M | -237K | -6.24M | -9.57M |
| Interest Income | n/a | n/a | 2.06M | 603K | 2.06M | 4.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -71.27M | -118.51M | -85.47M | -88.44M | 7.72M | -107.19M | -74.4M | -58.33M | -57.75M | -25.09M | -17.95M | -3.99M | -6.3M | -9.84M |
| Net Income | -70.87M | -118.51M | -83.41M | -88.19M | 8.41M | -106.37M | -74.01M | -58.13M | -57.28M | -24.69M | -17.75M | -3.96M | -6.27M | -9.81M |
| Selling & General & Admin | 26.53M | 27.65M | 30.26M | 29.41M | 21.75M | 17.75M | 15.32M | 11.87M | 9.23M | 7.77M | 6.18M | 3.52M | 2.83M | 2.41M |
| Research & Development | 32.8M | 108.51M | 91.88M | 82.7M | 107.85M | 113.82M | 75.53M | 48.52M | 49.25M | 21.22M | 15.07M | 8.69M | 4.6M | 7.16M |
| Other Expenses | 6.18M | n/a | 2.06M | 642K | 97K | 4.49M | 2.98M | 1.16M | 652K | 101K | 361K | n/a | n/a | -180K |
| Operating Expenses | 65.52M | 136.29M | 122.14M | 112.11M | 129.7M | 131.56M | 90.85M | 60.4M | 58.49M | 28.99M | 21.25M | 12.2M | 7.43M | 9.57M |
| Interest Expense | 8.47M | 604K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 126K | 3.76M | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 65.52M | 142.46M | 129.4M | 112.11M | 129.7M | 131.56M | 90.85M | 60.4M | 58.49M | 28.99M | 21.25M | 12.2M | 7.43M | 9.57M |
| Income Tax | -398K | n/a | -2.06M | -248K | -691K | -816K | -389K | -204K | -468K | -397K | -201K | -30K | -31K | -35K |
| Shares Outstanding (Basic) | 45.63M | 54.15M | 53.65M | 50.72M | 47.41M | 42.67M | 35.89M | 31.2M | 27.28M | 24.62M | 20.88M | 21.84M | 6.18M | 6.18M |
| Shares Outstanding (Diluted) | 45.63M | 54.15M | 53.65M | 50.72M | 47.92M | 42.67M | 35.89M | 31.2M | 27.28M | 24.62M | 20.97M | 21.84M | 6.18M | 6.18M |
| EPS (Basic) | -1.55 | -2.19 | -1.55 | -1.74 | 0.18 | -2.49 | -2.06 | -1.86 | -2.1 | -1 | -0.85 | -0.18 | -1.01 | -1.59 |
| EPS (Diluted) | -1.55 | -2.19 | -1.55 | -1.74 | 0.18 | -2.49 | -2.06 | -1.86 | -2.1 | -1 | -0.85 | -0.18 | -1.01 | -1.59 |
| EBITDA | -62.6M | -117.65M | -83.8M | -88.19M | 5.59M | -111.48M | -77.01M | -58.99M | -56.94M | -24.35M | -17.29M | 552K | -5.21M | -8.58M |
| Depreciation & Amortization | 192K | 259K | 1.67M | 1.55M | 1.01M | 799K | 370K | 495K | 1.47M | 839K | 783K | 789K | 1.02M | 1.17M |